Mounjaro is really a dual GIP and GLP-one receptor agonist, although Wegovy acts completely within the GLP-1 receptor. Mounjaro could have a much better impact on human body pounds, but is not really exclusively accredited for weight loss. Like Wegovy, Mounjaro is injected when each week.To become eligible, you have to have a BMI of 30 or increased